The US Food and Drug Administration cleared the way for marketing of the first device to use artificial intelligence based on machine learning to help detect lesions during colonoscopy.
The new dosing schedule is in addition to the approved weekly dosage regimen.
The COVID-19 pandemic sheds new light on existing access challenges in preventive health care.
Investigators explored the mechanism by which solid tumors appear to resist immune checkpoint inhibitor therapies.
Researchers analyzed the impact of colonoscopists’ performance on colorectal cancer risk following adenoma removal.
A new CADe software for colorectal polyp detection was validated and compared against a composite reference standard of experienced endoscopists and CADe detection.
Investigators examined the effects of antithrombotic drugs on fecal immunochemical tests (FITs) for detection of colorectal neoplasms (CN).
Researchers investigated whether endoscopic resection of T1 CRC before secondary surgery adversely affects recurrence risk.
Researchers aimed to evaluate the safety and efficacy of ESD throughout North America.
Cancer survivors have poorer ambulatory function, which is associated with increased mortality.
